FindTrial
Sign In

Ophthalmic manifestations and correlation with serum levels of VEGF-D in COVID-19 recovered subjects

Evaluation of ophthalmic manifestations and correlation with serum level of Vascular endothelial growth factor-D in COVID-19 recovered subjects

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/09/036975
Enrollment
80
Registered
2021-09-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: H00-H59- Diseases of the eye and adnexa

Interventions

None listed

Sponsors

ARCHANA T R
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: who have recovered from SARS-CoV-2 diseases

Exclusion criteria

Exclusion criteria: Subjects who had undergone any ocular or cranial surgery other than uneventful cataract surgery Subjects having pre-existing ocular pathology like retinal diseases, uveitis, media opacities and glaucoma; or central nervous system disease like tumors, demyelination, degeneration, etc.

Design outcomes

Primary

MeasureTime frame
Serum Vascular Endothelial Growth Factor-D levels Timepoint: 1 year—

Secondary

MeasureTime frame
Best Corrected Visual Acuity Posterior segment Optical Coherence Tomography parameters Timepoint: 1 year—

Countries

India

Contacts

Public ContactArchana T R

Guru Nanak Eye Center

punitasodhi222@gmail.com9891373756

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026